Literature DB >> 1357703

A two-year prospective study of treatment compliance in patients with schizophrenia.

A Buchanan1.   

Abstract

The study is a prospective investigation of the factors associated with treatment compliance in 61 patients discharged from hospital with a ward diagnosis of schizophrenia. All cases were classified using reliable diagnostic criteria and all were followed up for two years. Compliance was assessed by inspection of records and by analysis of urine. Sociodemographic factors and illness variables were unrelated to compliance. Some aspects of a patient's insight and attitude, namely, a belief that medication had helped during the admission, a stated willingness to take treatment after discharge and a generally optimistic outlook, were associated with improved compliance. Other variables which showed such an association were the absence of the drug side-effect akinesia, good previous compliance and voluntary, as opposed to compulsory, admission to hospital.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1357703     DOI: 10.1017/s0033291700038228

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  32 in total

1.  Determinants of anti-psychotic medication compliance in a multicultural population.

Authors:  S J Ziguras; S Klimidis; T J Lambert; A C Jackson
Journal:  Community Ment Health J       Date:  2001-06

2.  Social interaction and drug attitude effectiveness in patients with schizophrenia.

Authors:  Jui-Kang Tsai; Wen-Kuo Lin; For-Wey Lung
Journal:  Psychiatr Q       Date:  2011-12

Review 3.  Correlates and long-term consequences of poor insight in patients with schizophrenia. A systematic review.

Authors:  Tania M Lincoln; Eva Lüllmann; Winfried Rief
Journal:  Schizophr Bull       Date:  2007-02-08       Impact factor: 9.306

4.  WAY-163909, a 5-HT2C agonist, enhances the preclinical potency of current antipsychotics.

Authors:  Steven M Grauer; Radka Graf; Rachel Navarra; Amy Sung; Sheree F Logue; Gary Stack; Christine Huselton; Zhi Liu; Thomas A Comery; Karen L Marquis; Sharon Rosenzweig-Lipson
Journal:  Psychopharmacology (Berl)       Date:  2008-12-20       Impact factor: 4.530

Review 5.  Tactics and technologies to manage nonadherence in patients with schizophrenia.

Authors:  William M Glazer; Mathew J Byerly
Journal:  Curr Psychiatry Rep       Date:  2008-08       Impact factor: 5.285

6.  Cost effectiveness of long-acting risperidone injection versus alternative antipsychotic agents in patients with schizophrenia in the USA.

Authors:  Natalie C Edwards; Julie C Locklear; Marcia F T Rupnow; Ronald J Diamond
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

7.  Partial adherence to antipsychotic medication impacts the course of illness in patients with schizophrenia: a review.

Authors:  Prakash S Masand; Miquel Roca; Martin S Turner; John M Kane
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

8.  What's in name? Psychiatric epidemiology and social psychiatry at the turn of the century.

Authors:  P Bebbington
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1997-01       Impact factor: 4.328

9.  Evaluating mental health services in a Greek community. The factor of non-compliance to therapy.

Authors:  Dimitris C Anagnostopoulos; Maria Vlassopoulos; Helen Lazaratou; Chara Tzavara; George Zelios; Dimitris Ploumpidis
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-05-26       Impact factor: 4.785

10.  Predicting pharmacokinetic stability by multiple oral administration of atypical antipsychotics.

Authors:  Akihide Wakamatsu; Kazuo Aoki; Yojiro Sakiyama; Takashi Ohnishi; Makoto Sugita
Journal:  Innov Clin Neurosci       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.